While recent studies have underscored the beneficial effects of GLP-1R agonists in the context of PCOS (Nylander et al. 2017, Zhang et al. 2023a,b, Zhou et al. 2023), their impact on the ovaries in diet-induced obesity remains unclear. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.